Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
These clinically meaningful results support the use of trastuzumab deruxtecan as second-line therapy in patients with Gastric Cancer / Gastric adenocarcinoma / Stomach cancer (HER2 m) or gastro-oesophageal junction cancer
Therapy with trastuzumab deruxtecan led to significant improvements in response and overall survival, as compared with standard therapies, among patients with Gastric Cancer / Gastric adenocarcinoma / Stomach cancer (HER2 m). Myelosuppression and interstitial lung disease were the notable toxic effe…